| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CCDC66_0004000 | Exon-Exon | chr3:56597712-56652240 | chr3:56563684-56618212 | 183 nt | 0.3716 |
| hsa_CCDC66_0003100 | Exon-Exon | chr3:56597712-56653555 | chr3:56563684-56619527 | 2533 nt | 0.3794 |
| hsa_CCDC66_0004100 | Exon-Exon | chr3:56597712-56653929 | chr3:56563684-56619901 | 131 nt | 0.4351 |
| hsa_CCDC66_0004200 | Exon-Exon | chr3:56597911-56600766 | chr3:56563883-56566738 | 145 nt | 0.3103 |
| hsa_CCDC66_0004300 | Exon-Exon | chr3:56597998-56601081 | chr3:56563970-56567053 | 426 nt | 0.3732 |
| hsa_CCDC66_0004400 | Exon-Exon | chr3:56597998-56605330 | chr3:56563970-56571302 | 222 nt | 0.3559 |
| hsa_CCDC66_0004500 | Exon-Intron | chr3:56598001-56606456 | chr3:56563973-56572428 | 637 nt | 0.3721 |
| hsa_chr3_0745500 | Intergenic-Intergenic | chr3:56598075-56605277 | chr3:56564047-56571249 | 148 nt | 0.3378 |
| hsa_CCDC66_0004600 | Intron-Exon-Intron | chr3:56599617-56601081 | chr3:56565589-56567053 | 110 nt | 0.4273 |
| hsa_CCDC66_0004800 | Intron-Exon-Intron | chr3:56599666-56628056 | chr3:56565638-56594028 | 91 nt | 0.4725 |
A study in human lung adenocarcinoma cells demonstrated that the circCCDC66 increases epithelial-mesenchymal transition and drug resistance [Huang et al. DOI:10.3390/cells11091381].